Last data update: May 13, 2024. (Total: 46773 publications since 2009)
Records 1-1 (of 1 Records) |
Query Trace: Hocevar SA[original query] |
---|
Update: Interim guidance for health care professionals evaluating and caring for patients with suspected e-cigarette, or vaping, product use-associated lung injury and for reducing the risk for rehospitalization and death following hospital discharge - United States, December 2019
Evans ME , Twentyman E , Click ES , Goodman AB , Weissman DN , Kiernan E , Hocevar SA , Mikosz CA , Danielson M , Anderson KN , Ellington S , Lozier MJ , Pollack LA , Rose DA , Krishnasamy V , Jones CM , Briss P , King BA , Wiltz JL . MMWR Morb Mortal Wkly Rep 2020 68 (5152) 1189-1194 What is already known on this topic? In a recent examination of rehospitalization and death among previously hospitalized patients with e-cigarette or vaping, product use–associated lung injury (EVALI), at least one quarter of rehospitalizations and deaths occurred within 2 days of discharge; comorbidities were common among patients who were rehospitalized or who died after discharge. What is added by this report? Updated guidance recommends posthospitalization outpatient follow-up, optimally within 48 hours of discharge, and emphasizes the importance of preparation for hospital discharge and postdischarge care coordination to reduce risk of rehospitalization and death among hospitalized EVALI patients. What are the implications for public health practice? Incorporating this updated guidance into the management of hospitalized EVALI patients might reduce EVALI-associated morbidity and mortality. © 2020 Department of Health and Human Services. All rights reserved. |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure